Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer

By afschroeder • August 21, 2026

Silverstein J, Alomaja O, Chatram D, Hajiabbasi M, Shachar E, Tseng CH, Thaker S, Bardia A, Karlan B, Hendrickson AW, Konecny GE. Real-world clinical outcomes of Trastuzumab Deruxtecan in HER2-expressing ovarian and endometrial Cancer. Gynecol Oncol Rep. 2026 Aug 12;66:102183. doi: 10.1016/j.gore.2026.102183. PMID: 42621866; PMCID: PMC13487597.

Tags: Antibody-drug conjugates, DOM STAT, Endometrial cancer, Fellow, General Internal Medicine, Hematology/Oncology, Hospitalist, ovarian cancer, Publications, real-world outcomes, trastuzumab deruxtecan

Critical Rheumatic Mitral Stenosis Unmasked During Pregnancy Complicated by Preeclampsia With Severe Features and Managed With Urgent Balloon Mitral Valvuloplasty

Gorsi U, Kim N, Sukhija R, Kumar J, Nabavizadeh P. Critical Rheumatic Mitral Stenosis Unmasked During Pregnancy Complicated by Preeclampsia With Severe Features and Managed[...]

Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine

Mataraarachchi NE, Dellinger OD 3rd, Babakhanians A. Opioid Toxicity Associated With Tirzepatide in a Patient on Chronic Oral Morphine. Cureus. 2026 Aug 28;18(8):e115380. doi: 10.7759/cureus.115380.[...]

Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2 Diabetes and CKD

Htoo PT, Patorno E, Ortega-Montiel J, Wexler DJ, Orkaby A, Paik JM. Comparative Renal Effectiveness of GLP-1RA and SGLT2i in US Veterans with Type 2[...]